| |
|
Form Serial Number: |
DA20261008E00529
|
| 1.
Date of relevant event: |
06/10/2026
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02652 |
| 4.
Name of listed corporation: |
CF PharmTech, Inc. - H Shares |
| 5.
Class of shares: |
H Shares |
| 6.
Number of issued shares in class: |
323,971,286 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
LIANG |
| (Other names) |
Bill Wenqing |
|
|
|
| 10.
Name of director (Chinese): |
梁文青 |
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 1101 | The number of shares in which you are interested has increased because:
you purchased the shares |
|
| 2201 | Interest of corporation controlled by you |
|
| 2201 | Interest of corporation controlled by you |
|
19,300 |
HKD |
6.9650 |
6.9216 |
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 60,697,233 | 18.74 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 60,716,533 | 18.74 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
| 2103 | Interests held jointly with another person |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | | |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| 嶺頭投資有限公司 | Unit D, 16/F, One Capital Place, 18 Luard Road, Wan Chai, Hong Kong | LIANG Bill Wenqing | 100.00 | N | |
| 嶺頭投資有限公司 | Unit D, 16/F, One Capital Place, 18 Luard Road, Wan Chai, Hong Kong | LIANG Bill Wenqing | 100.00 | Y | |
| 蘇州嶺頭投資管理企業（有限合夥） | 蘇州市漕湖街道錢涇路1 號漕湖大廈19 樓1941 房屋 | 嶺頭投資有限公司 | 100.00 | Y | |
| 蘇州閩美投資管理企業（有限合夥） | 蘇州市漕湖街道錢涇路1 號漕湖大廈19 樓1941 房屋 | 蘇州嶺頭投資管理企業（有限合夥） | 100.00 | Y | |
| 蘇州遠辰企業管理中心（有限合夥） | 蘇州市漕湖街道錢涇路1 號漕湖大廈19 樓1941 房屋 | 蘇州嶺頭投資管理企業（有限合夥） | 100.00 | Y | |
| 蘇州沃倫企業管理中心（有限合夥） | 蘇州市漕湖街道錢涇路1 號漕湖大廈19 樓1941 房屋 | 蘇州嶺頭投資管理企業（有限合夥） | 100.00 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| 蘇州美中瑞投資管理企業（有限合夥） | Addresses of individuals are not displayed. | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| | | |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
Pursuant to Acting-in-Concert Agreement, Dr. LIANG Bill Wenqing and Dr. LI LI BOVET are parties acting in concert. As such, under the SFO, each of Dr. LIANG and Dr. LI LI BOVET is deemed to be interested in the Shares the other is interested in.
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
08/10/2026
(dd/mm/yyyy)
|
| |